anti-MeV antibody product blog
Tags: Antibody; Monoclonal Antibody; Measles Phosphoprotein; anti-MeV antibody; MeV;
The MeV n/a (Catalog #MBS190956) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Measles Phosphoprotein can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunoblot (IB), Immunocytochemistry (ICC).ELISA: Use at 0.1-1.0ug/ml.
Immunoblotting: Use at 1-5ug/ml. A band of ~70kDa is detected
Immunocytochemistry: Use at 2-10ug/ml on virus-infected cells. Researchers should empirically determine the suitability of the MeV n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Measles virus (MeV) is an enveloped RNA virus in the Morbillivirus genus of the Paramyxoviridae family. Its non-segmented, negative-sense, single-stranded RNA genome is encapsidated by the viral nucleoprotein (N) within a helical nucleocapsid. Transcription and replication are carried out on this N:RNA complex by the viral polymerase complex which consists of two components, the large protein (L) and the phosphoprotein (P). MeV N consists of two regions: a structured N-terminal moiety, NCORE (aa 1-400), which contains all the regions necessary for self-assembly and RNA-binding, and a C-terminal domain, NTAIL(aa 401-525) that is intrinsically unstructured and is exposed at the surface of the viral nucleocapsid.
Antigen: Recombinant Measles virus phosphoprotein. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MeV are readily searchable from our website. Different antibodies against the same target such as MeV may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.